期刊
JOURNAL OF BONE AND MINERAL METABOLISM
卷 36, 期 6, 页码 691-699出版社
SPRINGER JAPAN KK
DOI: 10.1007/s00774-017-0893-9
关键词
Parathyroid hormone (1-34); Menaquinone-4; Vitamin K-2; Implant; Osseointegration
资金
- Natural Science Foundation of Zhejiang Province [LY16H250002]
The objective of this study was to investigate the effects of human parathyroid hormone (1-34) (PTH1-34; PTH) plus menaquinone-4 (vitamin K-2; MK) on the osseous integration of hydroxyapatite (HA)-coated implants in osteoporotic rats. Ovariectomized female Sprague-Dawley rats were used for the study. Twelve weeks after bilateral ovariectomy, HA-coated titanium implants were inserted bilaterally in the femoral medullary canal of the remaining 40 ovariectomized rats. All animals were then randomly assigned to four groups: Control, MK, PTH and PTH+MK. The rats from groups MK, PTH and PTH+MK received vitamin K-2 (30mg/kg/day), PTH1-34 (60g/kg, three times a week), or both for 12weeks. Thereafter, serum levels of -carboxylated osteocalcin (Gla-OC) were quantitated by ELISA and the bilateral femurs of rats were harvested for evaluation. The combination of PTH and MK clearly increased the serum levels of Gla-OC (a specific marker for bone formation) compared to PTH or MK alone. The results of our study indicated that all treated groups had increased new bone formation around the surface of implants and increased push-out force compared to Control. In addition, PTH+MK treatment showed the strongest effects in histological, micro-computed tomography and biomechanical tests. In summary, our results confirm that treatment with PTH1-34 and MK together may have a therapeutic advantage over PTH or MK monotherapy on bone healing around HA-coated implants in osteoporotic rats.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据